+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Specialty Enzymes Market By Application, By Source, By Type: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 245 Pages
  • June 2022
  • Region: Global
  • Allied Market Research
  • ID: 5670856
The global specialty enzymes market was valued at $1,166.1 million in 2021, and is projected to reach $2,176.0 million by 2031, registering a CAGR of 6.7% from 2022 to 2031.

Enzymes are proteins that help speed up metabolism or chemical reactions in body. Specialty enzymes have applications in various industries such as pharmaceuticals, diagnostics, and food industries. These specialty enzymes can be derived from micro-organisms, plants, and animal sources.

Rise in prevalence of chronic diseases such as cancer and rheumatoid arthritis drive growth of the market. For instance, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Enzymes empower the immune system to eradicate unwanted cells on its own. Enzymes such as lipoprotein lipase (LPL), lysozyme, and asparaginase are utilized in the treatment of cancer. Thus, rise in prevalence of cancer drives growth of the market. In addition, enzymes are used for the digestive diseases and immunodeficiency disorders, which further boosts demand for specialty enzymes.

Furthermore, expansion of food industries drives demand of specialty enzymes. Enzymes such as lipases, amylases, proteases, rennet, pectinases, invertases, cellulases, and glucose oxidase play an important role in the food processing industry. For instance, according to the U.S. national institute of standards and technology (NIST), in 2021, the food and beverage industry is the third largest contributor to the overall U.S. manufacturing gross domestic product. Thus, increase in application of enzymes in the food industry and surge in expanding food processing industry drives growth of the market.

Moreover, increase in R&D activities for development of specialty enzymes, rise in clinical trials for medicinal application of enzymes, and novel product launches in the market by key players boost the market growth. For instance, Jazz Pharmaceuticals plc, a leading biologics company, announced positive results from a Phase 2/3 trial, developed and conducted in close collaboration with the Children's Oncology Group (COG), evaluating the intramuscular (IM) administration of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in adult and pediatric patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) who have developed hypersensitivity to an E. coli-derived asparaginase. However, complexities developed in biosimilars hinder growth of the market.

The specialty enzymes market is segmented on the basis of application, source, type, and region. By application, the market is classified into pharmaceuticals, biotechnology research & development, and diagnostics. On the basis of source, it is divided into microorganisms, plants, and animals. By type, it is divided into carbohydrase, proteases, lipases, polymerases & nucleases, and other enzymes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Alphazyme LLC, Amano Enzyme, Antozyme Biotech, Enzyme Development Corporation, BBI Solution, Biocatalyst, Novoenzymes, Specialty Enzymes and Probiotics, International Flavors and Fragrances Inc., and Enzyme Supplies Ltd.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current specialty enzymes market trends from 2022 to 2031 to identify the prevailing opportunities along with the strategic assessment.

The specialty enzymes market forecast is studied from 2022 to 2031.

The market size and estimations are based on a comprehensive analysis of key developments in the specialty enzymes industry.

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the specialty enzymes market.

Key Market Segments

By Application

  • Pharmaceuticals
  • Biotechnology research and development
  • Diagnostics

By Source

  • Microorganisms
  • Plants
  • Animal

By Type

  • Carbohydrases
  • Proteases
  • Lipases
  • Polymerases nucleases
  • Other enzymes

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Turkey
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Antozyme Biotech
  • Enzyme Development Corporation
  • BBI Solutions
  • Biocatalyst
  • Novozymes
  • Specialty Enzyme and Probiotics
  • International Flavor & Fragrance Inc
  • Enzyme Supplies Limited
  • Alphazyme LLC
  • Amano Enzyme
Frequently Asked Questions about the Global Specialty Enzymes Market

What is the estimated value of the Global Specialty Enzymes Market?

The Global Specialty Enzymes Market was estimated to be valued at $1166.1 million in 2021.

What is the growth rate of the Global Specialty Enzymes Market?

The growth rate of the Global Specialty Enzymes Market is 6.4%, with an estimated value of $2176 million by 2031.

What is the forecasted size of the Global Specialty Enzymes Market?

The Global Specialty Enzymes Market is estimated to be worth $2176 million by 2031.

Who are the key companies in the Global Specialty Enzymes Market?

Key companies in the Global Specialty Enzymes Market include Antozyme Biotech, Enzyme Development Corporation, Bbi Solutions, Biocatalyst, Novozymes, Specialty Enzyme and Probiotics, International Flavor & Fragrance Inc, Enzyme Supplies Limited, Alphazyme LLC and Amano Enzyme.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SPECIALTY ENZYMES MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Pharmaceuticals
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Biotechnology research and development
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Diagnostics
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SPECIALTY ENZYMES MARKET, BY SOURCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Microorganisms
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Plants
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Animal
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: SPECIALTY ENZYMES MARKET, BY TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Carbohydrases
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Proteases
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Lipases
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Polymerases & nucleases
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Other enzymes
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: SPECIALTY ENZYMES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Application
7.2.3 North America Market size and forecast, by Source
7.2.4 North America Market size and forecast, by Type
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Application
7.2.5.1.2 Market size and forecast, by Source
7.2.5.1.3 Market size and forecast, by Type
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Application
7.2.5.2.2 Market size and forecast, by Source
7.2.5.2.3 Market size and forecast, by Type
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Application
7.2.5.3.2 Market size and forecast, by Source
7.2.5.3.3 Market size and forecast, by Type
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Application
7.3.3 Europe Market size and forecast, by Source
7.3.4 Europe Market size and forecast, by Type
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Application
7.3.5.1.2 Market size and forecast, by Source
7.3.5.1.3 Market size and forecast, by Type
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Application
7.3.5.2.2 Market size and forecast, by Source
7.3.5.2.3 Market size and forecast, by Type
7.3.5.3 United Kingdom
7.3.5.3.1 Market size and forecast, by Application
7.3.5.3.2 Market size and forecast, by Source
7.3.5.3.3 Market size and forecast, by Type
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Application
7.3.5.4.2 Market size and forecast, by Source
7.3.5.4.3 Market size and forecast, by Type
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Application
7.3.5.5.2 Market size and forecast, by Source
7.3.5.5.3 Market size and forecast, by Type
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Application
7.3.5.6.2 Market size and forecast, by Source
7.3.5.6.3 Market size and forecast, by Type
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Application
7.4.3 Asia-Pacific Market size and forecast, by Source
7.4.4 Asia-Pacific Market size and forecast, by Type
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Application
7.4.5.1.2 Market size and forecast, by Source
7.4.5.1.3 Market size and forecast, by Type
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Application
7.4.5.2.2 Market size and forecast, by Source
7.4.5.2.3 Market size and forecast, by Type
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Application
7.4.5.3.2 Market size and forecast, by Source
7.4.5.3.3 Market size and forecast, by Type
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Application
7.4.5.4.2 Market size and forecast, by Source
7.4.5.4.3 Market size and forecast, by Type
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Application
7.4.5.5.2 Market size and forecast, by Source
7.4.5.5.3 Market size and forecast, by Type
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Application
7.4.5.6.2 Market size and forecast, by Source
7.4.5.6.3 Market size and forecast, by Type
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Application
7.5.3 LAMEA Market size and forecast, by Source
7.5.4 LAMEA Market size and forecast, by Type
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Application
7.5.5.1.2 Market size and forecast, by Source
7.5.5.1.3 Market size and forecast, by Type
7.5.5.2 Turkey
7.5.5.2.1 Market size and forecast, by Application
7.5.5.2.2 Market size and forecast, by Source
7.5.5.2.3 Market size and forecast, by Type
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Application
7.5.5.3.2 Market size and forecast, by Source
7.5.5.3.3 Market size and forecast, by Type
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Application
7.5.5.4.2 Market size and forecast, by Source
7.5.5.4.3 Market size and forecast, by Type
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Antozyme Biotech
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Enzyme Development Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 BBI Solutions
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Biocatalyst
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Novozymes
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Specialty Enzyme and Probiotics
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 International Flavor & Fragrance Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Enzyme Supplies Limited
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Alphazyme LLC
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Amano Enzyme
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 2. Specialty Enzymes Market Size, for Pharmaceuticals, by Region, 2021-2031 ($Million)
Table 3. Specialty Enzymes Market for Pharmaceuticals by Country, 2021-2031 ($Million)
Table 4. Specialty Enzymes Market Size, for Biotechnology Research and Development, by Region, 2021-2031 ($Million)
Table 5. Specialty Enzymes Market for Biotechnology Research and Development by Country, 2021-2031 ($Million)
Table 6. Specialty Enzymes Market Size, for Diagnostics, by Region, 2021-2031 ($Million)
Table 7. Specialty Enzymes Market for Diagnostics by Country, 2021-2031 ($Million)
Table 8. Global Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 9. Specialty Enzymes Market Size, for Microorganisms, by Region, 2021-2031 ($Million)
Table 10. Specialty Enzymes Market for Microorganisms by Country, 2021-2031 ($Million)
Table 11. Specialty Enzymes Market Size, for Plants, by Region, 2021-2031 ($Million)
Table 12. Specialty Enzymes Market for Plants by Country, 2021-2031 ($Million)
Table 13. Specialty Enzymes Market Size, for Animal, by Region, 2021-2031 ($Million)
Table 14. Specialty Enzymes Market for Animal by Country, 2021-2031 ($Million)
Table 15. Global Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 16. Specialty Enzymes Market Size, for Carbohydrases, by Region, 2021-2031 ($Million)
Table 17. Specialty Enzymes Market for Carbohydrases by Country, 2021-2031 ($Million)
Table 18. Specialty Enzymes Market Size, for Proteases, by Region, 2021-2031 ($Million)
Table 19. Specialty Enzymes Market for Proteases by Country, 2021-2031 ($Million)
Table 20. Specialty Enzymes Market Size, for Lipases, by Region, 2021-2031 ($Million)
Table 21. Specialty Enzymes Market for Lipases by Country, 2021-2031 ($Million)
Table 22. Specialty Enzymes Market Size, for Polymerases & Nucleases, by Region, 2021-2031 ($Million)
Table 23. Specialty Enzymes Market for Polymerases & Nucleases by Country, 2021-2031 ($Million)
Table 24. Specialty Enzymes Market Size, for Other Enzymes, by Region, 2021-2031 ($Million)
Table 25. Specialty Enzymes Market for Other Enzymes by Country, 2021-2031 ($Million)
Table 26. Specialty Enzymes Market, by Region, 2021-2031 ($Million)
Table 27. North America Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 28. North America Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 29. North America Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 30. North America Specialty Enzymes Market, by Country, 2021-2031 ($Million)
Table 31. U.S. Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 32. U.S. Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 33. U.S. Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 34. Canada Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 35. Canada Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 36. Canada Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 37. Mexico Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 38. Mexico Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 39. Mexico Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 40. Europe Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 41. Europe Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 42. Europe Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 43. Europe Specialty Enzymes Market, by Country, 2021-2031 ($Million)
Table 44. Germany Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 45. Germany Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 46. Germany Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 47. France Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 48. France Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 49. France Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 50. United Kingdom Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 51. United Kingdom Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 52. United Kingdom Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 53. Italy Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 54. Italy Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 55. Italy Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 56. Spain Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 57. Spain Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 58. Spain Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 59. Rest of Europe Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 60. Rest of Europe Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 61. Rest of Europe Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 62. Asia-Pacific Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 63. Asia-Pacific Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 64. Asia-Pacific Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 65. Asia-Pacific Specialty Enzymes Market, by Country, 2021-2031 ($Million)
Table 66. Japan Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 67. Japan Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 68. Japan Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 69. China Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 70. China Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 71. China Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 72. Australia Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 73. Australia Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 74. Australia Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 75. India Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 76. India Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 77. India Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 78. South Korea Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 79. South Korea Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 80. South Korea Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 81. Rest of Asia-Pacific Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 82. Rest of Asia-Pacific Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 83. Rest of Asia-Pacific Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 84. LAMEA Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 85. LAMEA Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 86. LAMEA Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 87. LAMEA Specialty Enzymes Market, by Country, 2021-2031 ($Million)
Table 88. Brazil Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 89. Brazil Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 90. Brazil Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 91. Turkey Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 92. Turkey Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 93. Turkey Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 94. South Africa Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 95. South Africa Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 96. South Africa Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 97. Rest of LAMEA Specialty Enzymes Market, by Application, 2021-2031 ($Million)
Table 98. Rest of LAMEA Specialty Enzymes Market, by Source, 2021-2031 ($Million)
Table 99. Rest of LAMEA Specialty Enzymes Market, by Type, 2021-2031 ($Million)
Table 100. Antozyme Biotech: Company Snapshot
Table 101. Antozyme Biotech: Operating Segments
Table 102. Antozyme Biotech: Product Portfolio
Table 103. Antozyme Biotech: Net Sales
Table 104. Antozyme Biotech: Key Stratergies
Table 105. Enzyme Development Corporation: Company Snapshot
Table 106. Enzyme Development Corporation: Operating Segments
Table 107. Enzyme Development Corporation: Product Portfolio
Table 108. Enzyme Development Corporation: Net Sales
Table 109. Enzyme Development Corporation: Key Stratergies
Table 110. Bbi Solutions: Company Snapshot
Table 111. Bbi Solutions: Operating Segments
Table 112. Bbi Solutions: Product Portfolio
Table 113. Bbi Solutions: Net Sales
Table 114. Bbi Solutions: Key Stratergies
Table 115. Biocatalyst: Company Snapshot
Table 116. Biocatalyst: Operating Segments
Table 117. Biocatalyst: Product Portfolio
Table 118. Biocatalyst: Net Sales
Table 119. Biocatalyst: Key Stratergies
Table 120. Novozymes: Company Snapshot
Table 121. Novozymes: Operating Segments
Table 122. Novozymes: Product Portfolio
Table 123. Novozymes: Net Sales
Table 124. Novozymes: Key Stratergies
Table 125. Specialty Enzyme and Probiotics: Company Snapshot
Table 126. Specialty Enzyme and Probiotics: Operating Segments
Table 127. Specialty Enzyme and Probiotics: Product Portfolio
Table 128. Specialty Enzyme and Probiotics: Net Sales
Table 129. Specialty Enzyme and Probiotics: Key Stratergies
Table 130. International Flavor & Fragrance Inc: Company Snapshot
Table 131. International Flavor & Fragrance Inc: Operating Segments
Table 132. International Flavor & Fragrance Inc: Product Portfolio
Table 133. International Flavor & Fragrance Inc: Net Sales
Table 134. International Flavor & Fragrance Inc: Key Stratergies
Table 135. Enzyme Supplies Limited: Company Snapshot
Table 136. Enzyme Supplies Limited: Operating Segments
Table 137. Enzyme Supplies Limited: Product Portfolio
Table 138. Enzyme Supplies Limited: Net Sales
Table 139. Enzyme Supplies Limited: Key Stratergies
Table 140. Alphazyme LLC: Company Snapshot
Table 141. Alphazyme LLC: Operating Segments
Table 142. Alphazyme LLC: Product Portfolio
Table 143. Alphazyme LLC: Net Sales
Table 144. Alphazyme LLC: Key Stratergies
Table 145. Amano Enzyme: Company Snapshot
Table 146. Amano Enzyme: Operating Segments
Table 147. Amano Enzyme: Product Portfolio
Table 148. Amano Enzyme: Net Sales
Table 149. Amano Enzyme: Key Stratergies
List of Figures
Figure 1. Specialty Enzymes Market Segmentation
Figure 2. Specialty Enzymes Market,2021-2031
Figure 3. Specialty Enzymes Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Specialty Enzymes Market:Drivers, Restraints and Opportunities
Figure 12. Specialty Enzymes Market,By Application,2021(%)
Figure 13. Comparative Share Analysis of Pharmaceuticals Specialty Enzymes Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Biotechnology Research and Development Specialty Enzymes Market,2021-2031(%)
Figure 15. Comparative Share Analysis of Diagnostics Specialty Enzymes Market,2021-2031(%)
Figure 16. Specialty Enzymes Market,By Source,2021(%)
Figure 17. Comparative Share Analysis of Microorganisms Specialty Enzymes Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Plants Specialty Enzymes Market,2021-2031(%)
Figure 19. Comparative Share Analysis of Animal Specialty Enzymes Market,2021-2031(%)
Figure 20. Specialty Enzymes Market,By Type,2021(%)
Figure 21. Comparative Share Analysis of Carbohydrases Specialty Enzymes Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Proteases Specialty Enzymes Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Lipases Specialty Enzymes Market,2021-2031(%)
Figure 24. Comparative Share Analysis of Polymerases & Nucleases Specialty Enzymes Market,2021-2031(%)
Figure 25. Comparative Share Analysis of Other Enzymes Specialty Enzymes Market,2021-2031(%)
Figure 26. Specialty Enzymes Market by Region,2021
Figure 27. U.S. Specialty Enzymes Market,2021-2031($Million)
Figure 28. Canada Specialty Enzymes Market,2021-2031($Million)
Figure 29. Mexico Specialty Enzymes Market,2021-2031($Million)
Figure 30. Germany Specialty Enzymes Market,2021-2031($Million)
Figure 31. France Specialty Enzymes Market,2021-2031($Million)
Figure 32. United Kingdom Specialty Enzymes Market,2021-2031($Million)
Figure 33. Italy Specialty Enzymes Market,2021-2031($Million)
Figure 34. Spain Specialty Enzymes Market,2021-2031($Million)
Figure 35. Rest of Europe Specialty Enzymes Market,2021-2031($Million)
Figure 36. Japan Specialty Enzymes Market,2021-2031($Million)
Figure 37. China Specialty Enzymes Market,2021-2031($Million)
Figure 38. Australia Specialty Enzymes Market,2021-2031($Million)
Figure 39. India Specialty Enzymes Market,2021-2031($Million)
Figure 40. South Korea Specialty Enzymes Market,2021-2031($Million)
Figure 41. Rest of Asia-Pacific Specialty Enzymes Market,2021-2031($Million)
Figure 42. Brazil Specialty Enzymes Market,2021-2031($Million)
Figure 43. Turkey Specialty Enzymes Market,2021-2031($Million)
Figure 44. South Africa Specialty Enzymes Market,2021-2031($Million)
Figure 45. Rest of LAMEA Specialty Enzymes Market,2021-2031($Million)
Figure 46. Top Winning Strategies, by Year
Figure 47. Top Winning Strategies, by Development
Figure 48. Top Winning Strategies, by Company
Figure 49. Product Mapping of Top 10 Players
Figure 50. Competitive Dashboard
Figure 51. Competitive Heatmap of Top 10 Key Players
Figure 52. Antozyme Biotech.: Net Sales ,($Million)
Figure 53. Enzyme Development Corporation.: Net Sales ,($Million)
Figure 54. Bbi Solutions.: Net Sales ,($Million)
Figure 55. Biocatalyst.: Net Sales ,($Million)
Figure 56. Novozymes.: Net Sales ,($Million)
Figure 57. Specialty Enzyme and Probiotics.: Net Sales ,($Million)
Figure 58. International Flavor & Fragrance Inc.: Net Sales ,($Million)
Figure 59. Enzyme Supplies Limited.: Net Sales ,($Million)
Figure 60. Alphazyme LLC.: Net Sales ,($Million)
Figure 61. Amano Enzyme.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Specialty Enzymes Market," the specialty enzymes market size was valued at $1.2 billion in 2021, and is estimated to reach $2.2 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.

Specialty enzymes are proteins that act as biocatalysts to accelerate the reaction and produce desired results in pharmaceuticals and diagnostics reactions. The demand for specialty enzyme has increased, owing to application of enzymes in various industries such as food, pharmaceuticals, and diagnostics.

Increase in prevalence of chronic diseases such as cancer and arthritis drives growth of the market. Alkaline phosphatase, carboxypeptidases, beta-glucosidases, and beta-lactamases are utilized in making anti-cancer drugs. For instance, according to the Globocan 2020, a report published by the WHO, lung cancer ranked second, in terms of patient count in Europe with estimated 477,534 newly diagnosed patients. Proteolytic enzyme bromelain was effective at reducing symptoms of pain, swelling, and joint stiffness in people with osteoarthritis. Thus, increase in prevalence of chronic diseases contributes toward growth of the market.

Furthermore, rise in number of geriatric populations drives growth of the specialty enzymes market. This population is more prone to chronic diseases. Thus, geriatric population signifies increase in patients of chronic diseases. For instance, according to the WHO, by 2050, the population of people aged 60 years and older will reach to 2.1 billion.

Furthermore, factors that drive growth of the specialty enzymes market share include increase in R&D for development of enzyme therapy, increase in clinical trials, new product launches, and rise in number of hospitals. For instance, in May 2020, MediWound Ltd., a fully-integrated biopharmaceutical company expanded the distribution of NexoBrid (Bromelain-based enzymatic debridement) in Europe for treatment of burns. Furthermore, rise in awareness and increase in acceptability of enzyme-based treatment by medical practitioners contributes toward growth of the specialty enzymes market.

The specialty enzymes market trends is segmented on the basis of application, source, type, and region. By application, the market is classified into pharmaceuticals, biotechnology research & development, and diagnostics. On the basis of source, it is divided into microorganisms, plants, and animals. By type, it is divided into carbohydrase, proteases, lipases, polymerases & nucleases, and other enzymes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA
.

On the basis of type, the market is divided into carbohydrase, proteases, lipases, polymerases & nucleases and other enzymes. The carbohydrases segment dominated the market in 2021, and this trend is expected to continue during the forecast period, as carbohydrase have widely used as ingredients and processing aids in distinct industries such as foods & beverages and pharmaceuticals. Thus, increase in consumption of processed foods & beverages drives growth of the market.

Depending on application, the market is classified into pharmaceuticals, biotechnology, and diagnostics. The pharmaceuticals segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to rise in demand for specialty enzymes in drug synthesis and increase in R&D activities for development of novel specialty enzymes contribute toward growth of the market. In addition, increase in prevalence of digestive diseases and cancer further drives growth of the market.

On the basis of source, the market is bifurcated into microorganisms, plants, and animals. The microorganisms segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to rise in use of amylases in biotechnology and pharmaceutical industries is expected to drive the microorganism-derived specialty enzymes market.

North America accounted for a majority of the global specialty enzymes market growth in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of cancer and presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of chronic diseases and high population base.

According to Onkar Sumant, Manager, Healthcare, “The gradual increase in the need of specialty enzymes in various industries such as pharmaceuticals and diagnostics sector fuels the growth of specialty enzymes market.”

Some of the key players operating in the global specialty enzymes industry include Alphazyme LLC, Amano Enzyme, Antozyme Biotech, Enzyme Development Corporation, BBI Solution, Biocatalyst, Novoenzymes, Specialty Enzymes and Probiotics, International Flavors and Fragrances Inc and Enzyme Supplies Ltd.

Key Findings of the Study

  • By type, the carbohydrases segment was the highest contributor to the specialty enzymes industry in 2021.
  • By application, the pharmaceuticals segment was the highest contributor to the market in 2021.
  • By source, the microorganism’s segment is projected to grow at a significant CAGR of 6.3% from 2022 to 2031.
  • By region, North America garnered largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.8% during the review period.

Companies Mentioned

  • Antozyme Biotech
  • Enzyme Development Corporation
  • Bbi Solutions
  • Biocatalyst
  • Novozymes
  • Specialty Enzyme and Probiotics
  • International Flavor & Fragrance Inc
  • Enzyme Supplies Limited
  • Alphazyme LLC
  • Amano Enzyme

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...